Triomune 30
Brand Name: Triomune 30
Composition: Lamivudine, Stavudine, and Nevirapine Tablets IP
Manufacturer: Cipla
Product Description
Medical Info
Triomune 30 is a fixed-dose combination medication formulated by Cipla to assist in the management and treatment of Human Immunodeficiency Virus (HIV) infection. Each tablet integrates three active antiretroviral agents: Lamivudine, Stavudine, and Nevirapine. These components work synergistically to inhibit viral replication, significantly reducing the viral load while helping to restore and preserve immune function. Designed for patient compliance, this three-in-one formulation simplifies complex treatment regimens by reducing daily pill burdens. It is critical to use this prescription-only medication under strict medical supervision to monitor efficacy, maintain optimal health outcomes, and mitigate potential side effects.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
